SCHEMBL232586

SCHEMBL232586

[CH]=CC=CC=CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL815298 1.00 TRPA1 (0.43)
SCHEMBL816679 1.00 TRPA1 (0.43)
SCHEMBL816616 1.00 TRPA1 (0.43)
SCHEMBL814955 1.00 TRPA1 (0.43)
SCHEMBL4817022 1.00 TRPA1 (0.43)
SCHEMBL816680 1.00 TRPA1 (0.43)
SCHEMBL817000 1.00 TRPA1 (0.43)
SCHEMBL817001 1.00 TRPA1 (0.43)
SCHEMBL815297 1.00 TRPA1 (0.43)
SCHEMBL817683 1.00 TRPA1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117342949-A Biaryl acid, linear polyaramide and cross-linked polyaramide and preparation method 江汉大学 2024-01-05 CN claimed
CN-116157397-A Heterocyclylpyridines as novel fungicides 拜耳公司 2023-05-23 CN claimed
CN-115955916-A Active compound combinations 拜耳公司 2023-04-11 CN claimed
CN-115803320-A Heterocyclyl pyrimidines and triazines as novel fungicides 拜耳公司 2023-03-14 CN claimed
US-20050171078-A1 Novel azacyclic ethynyl derivatives NEUROSEARCH (DK) 2005-08-04 US claimed
EP-1506205-A2 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH A/S (DK) 2005-02-16 EP claimed
WO-2003094830-A2 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH A/S (DK) 2003-11-20 WO claimed
CN-118317956-A Bis (hetero) aryl thioether oxadiazines as fungicidal compounds 拜耳公司 2024-07-09 CN disclosed
WO-2024137780-A1 PANK MODULATORS AND METHODS OF TREATMENT USING SAME YALE UNIVERSITY (US) 2024-06-27 WO disclosed
CN-117903036-A Synthesis and application of novel FXR (FXR) agonist 厦门市博瑞来医药科技有限公司 2024-04-19 CN disclosed
CN-117730082-A Synthesis of substituted tricyclic amides and analogs thereof 爱彼特生物制药公司 2024-03-19 CN disclosed
CN-117645642-A Compounds for RNA capping and uses thereof 广州市恒诺康医药科技有限公司 2024-03-05 CN disclosed
WO-2024038356-A1 SYNTHESIS OF SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS AND SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORPORATION (CA) 2024-02-22 WO disclosed
WO-2002002564-A1 ARYL AND HETEROARYL DIAZABICYCLOALKANES, THEIR PREPARATION AND USE NEUROSEARCH A/S (DK) 2002-01-10 WO disclosed
US-6215016-B1 HEMATOPOIETIC AGENTS; PREVENTING CYTOPENIA TORAY INDUSTRIES, INC. (JP) 2001-04-10 US disclosed
US-6100292-A Ketone derivatives and their medical applications TORAY INDUSTRIES, INC. (JP) 2000-08-08 US disclosed
EP-0980867-A1 KETONE DERIVATIVES AND MEDICINAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 2000-02-23 EP disclosed
EP-0841063-A1 KETONE DERIVATIVES AND MEDICINAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 1998-05-13 EP disclosed
US-4581225-A CARDIOTONIC AGENTS; A CATECHOLAMINE, DOBUTAMINE ELI LILLY AND COMPANY (US) 1986-04-08 US disclosed
EP-0160501-A2 Sustained release intranasal formulation and method of use thereof ELI LILLY AND COMPANY (US) 1985-11-06 EP disclosed